ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. ProPublica on Friday published never-before-released data ...

Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain uncertain ...

A federal appeals court in the US has declined to overturn an attempt by Novartis to block the launch of a generic version of its blockbuster heart failure drug Entresto. The US Court of Appeals for ...

A brand-name drug is the original version of a medication that’s FDA-approved to treat a specific condition. Generics contain exact copies of the active ingredient in the original branded drug (an ...

Democrats are ahead of Republicans by 6 percentage points on a generic congressional ballot, according to a poll released Thursday. In the Emerson College poll, 48.1 percent of respondents backed a ...

Investors are still coming out of one of the worst bond markets in history. Between the bond market’s dismal 2022 and the stock market’s downturn from the onset of the Russia-Ukraine war, the 2020s ...

Details concerning the Dapoxetine (30mg) medication encompass its pricing as well as its availability in various forms, including tablets, capsules, syrups, creams, gels, ointments, liquids, and ...

TADCO posts losses of SAR 49.2M in 9M 2025, SAR 24.1M in Q3 9 M 2025 TADCO incurs SAR 25.1M loss in H1 2025, SAR 18M in Q2 6 M 2025 TADCO trims losses to SAR 7.1M in Q1 2025 3 M 2025 TADCO loses SAR ...